Erg251 has complex and pleiotropic effects on sterol composition, azole susceptibility, filamentation, and stress response phenotypes.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
30 Jul 2024
Historique:
received: 31 01 2024
accepted: 03 07 2024
medline: 30 7 2024
pubmed: 30 7 2024
entrez: 30 7 2024
Statut: aheadofprint

Résumé

Ergosterol is essential for fungal cell membrane integrity and growth, and numerous antifungal drugs target ergosterol. Inactivation or modification of ergosterol biosynthetic genes can lead to changes in antifungal drug susceptibility, filamentation and stress response. Here, we found that the ergosterol biosynthesis gene ERG251 is a hotspot for point mutations during adaptation to antifungal drug stress within two distinct genetic backgrounds of Candida albicans. Heterozygous point mutations led to single allele dysfunction of ERG251 and resulted in azole tolerance in both genetic backgrounds. This is the first known example of point mutations causing azole tolerance in C. albicans. Importantly, single allele dysfunction of ERG251 in combination with recurrent chromosome aneuploidies resulted in bona fide azole resistance. Homozygous deletions of ERG251 caused increased fitness in low concentrations of fluconazole and decreased fitness in rich medium, especially at low initial cell density. Homozygous deletions of ERG251 resulted in accumulation of ergosterol intermediates consistent with the fitness defect in rich medium. Dysfunction of ERG251, together with FLC exposure, resulted in decreased accumulation of the toxic sterol (14-ɑ-methylergosta-8,24(28)-dien-3β,6α-diol) and increased accumulation of non-toxic alternative sterols. The altered sterol composition of the ERG251 mutants had pleiotropic effects on transcription, filamentation, and stress responses including cell membrane, osmotic and oxidative stress. Interestingly, while dysfunction of ERG251 resulted in azole tolerance, it also led to transcriptional upregulation of ZRT2, a membrane-bound Zinc transporter, in the presence of FLC, and overexpression of ZRT2 is sufficient to increase azole tolerance in wild-type C. albicans. Finally, in a murine model of systemic infection, homozygous deletion of ERG251 resulted in decreased virulence while the heterozygous deletion mutants maintain their pathogenicity. Overall, this study demonstrates that single allele dysfunction of ERG251 is a recurrent and effective mechanism of acquired azole tolerance. We propose that altered sterol composition resulting from ERG251 dysfunction mediates azole tolerance as well as pleiotropic effects on stress response, filamentation and virulence.

Identifiants

pubmed: 39078851
doi: 10.1371/journal.ppat.1012389
pii: PPATHOGENS-D-24-00236
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1012389

Informations de copyright

Copyright: © 2024 Zhou et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

I have read the journal’s policy and the authors of this manuscript have the following competing interests: Dr. MDP, M.D., is a Co-Founder and Chief Scientific Officer (CSO) of MicroRid Technologies Inc. The goal of MicroRid Technologies Inc. is to develop new antifungal agents for therapeutic use. All other authors declare no competing interests.

Auteurs

Xin Zhou (X)

Department of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota, United States of America.

Audrey Hilk (A)

Department of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota, United States of America.

Norma V Solis (NV)

Division of Infectious Diseases, Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center, Torrance, California, United States of America.

Nivea Pereira De Sa (N)

Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, United States of America.

Bode M Hogan (BM)

Gustavus Adolphus College, Department of Biology, Saint Peter, Minnesota, USA.

Tessa A Bierbaum (TA)

Gustavus Adolphus College, Department of Biology, Saint Peter, Minnesota, USA.

Maurizio Del Poeta (M)

Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, United States of America.
Division of Infectious Diseases, School of Medicine, Stony Brook University, Stony Brook, New York, United States of America.
Veterans Administration Medical Center, Northport, New York, United States of America.

Scott G Filler (SG)

Division of Infectious Diseases, Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center, Torrance, California, United States of America.
David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America.

Laura S Burrack (LS)

Gustavus Adolphus College, Department of Biology, Saint Peter, Minnesota, USA.

Anna Selmecki (A)

Department of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota, United States of America.

Classifications MeSH